Laddar...
Should patient groups accept money from drug companies? Yes
Patient groups provide valuable support and advocacy for vulnerable people but funding the work can be difficult. Alastair Kent argues that not accepting industry money will unnecessarily limit the groups' effectiveness, but Barbara Mintzes believes that the money undermines their independence
Sparad:
| Huvudupphovsman: | |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
BMJ Publishing Group Ltd.
2007
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1865450/ https://ncbi.nlm.nih.gov/pubmed/17478845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmj.39185.461968.AD |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|